+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 45Years - 75Years
All Genders
Healthy Volunteers
ID06995898

Evaluating Multi-Cancer Detection Blood Tests for Early Cancer Screening Among Adults Aged 45 to 75

Led by National Cancer Institute (NCI) · Updated on 2026-11-04

24000

Participants Needed

45

Research Sites

21 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are exploring how multi-cancer detection MCD tests might work as tools to screen for multiple cancers at once in adults aged 45 to 75 without cancer. The study aims to understand the performance of two different MCD tests compared to a control group and how patients and doctors handle both normal and abnormal test results. This feasibility study will inform future trials and help improve early cancer detection when treatment is most effective. Participants will be randomly assigned to one of three groups one group will undergo the Shield MCD test, another the Avantect MCD test, and the third will serve as a control group with blood collection only. Blood samples are collected at enrollment and again after one year. Participants at unblinded sites receive their test results, and those with abnormal findings follow up with their clinicians for further testing. After the active study period, participants are followed passively for up to 10 years. During the study, participants complete questionnaires and provide blood samples on schedule. Researchers collect medical record data and monitor participant adherence, diagnostic outcomes, anxiety related to testing, and the accuracy of the tests in predicting cancer origins. Primary outcomes include enrollment feasibility, questionnaire completion, blood sample provision, and follow-up retention. Secondary outcomes evaluate diagnostic resolution, complications, and psychological impact. This comprehensive approach helps assess the practical aspects of MCD testing and its potential role in cancer screening.

CONDITIONS

Brief Title

The Vanguard Study: Testing a New Way to Screen for Cancer

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here